The expression of APOBEC3H in head and neck squamous cell carcinoma is upregulated and may regulate the immune response through its demethylation activity, which has been identified as a potential target for immunotherapy of head and neck squamous cell carcinoma (Liu J et al., 2020). The gene discussed is APOBEC3H; the disease is head and neck squamous cell carcinoma.